As of 2024-07-27, the Fair Value of ACADIA Pharmaceuticals Inc (ACAD) is -0.14 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 19.14 USD, the upside of ACADIA Pharmaceuticals Inc is -100.75%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -235.30 | -281.60 | -167.90 | -216.00 | -61.29 | -192.42 |
| YoY growth | 4.04% | -19.68% | 40.38% | -28.65% | 71.63% | 13.54% |
| Market Cap (mil) | 3,162.31 |
| P/E | |
| Forward P/E |
| EPS | -0.01 |
| Avg earnings growth rate | 13.54% |
| TTM earnings | -1.75 |